QSC Peptidology
Compare/Retatrutide vs tirzepatide vs semaglutide

Retatrutide vs tirzepatide vs semaglutide

Semaglutide, tirzepatide and retatrutide are three incretin-based research peptides that differ mainly in how many receptors they activate: semaglutide acts on the GLP-1 receptor only, tirzepatide on the GLP-1 and GIP receptors, and retatrutide on the GLP-1, GIP and glucagon receptors. This page compares them side by side using the specifications and published test data on our own product pages. All QSC products are sold for laboratory research use only.

Side by side

 SemaglutideTirzepatideRetatrutide
Receptors activatedGLP-1 (single agonist)GLP-1 and GIP (dual agonist)GLP-1, GIP and glucagon (triple agonist)
StructureGLP-1 analog with two amino acid substitutions and a C18 fatty diacid chain on lysine 26, supporting albumin binding39-amino acid peptide with a C20 fatty diacid moiety for albumin bindingSynthetic 39-amino acid peptide
Typical research focusReference GLP-1 receptor agonist in studies of glucose-stimulated insulin secretion, satiety signalling, gastric emptying and central reward pathwaysComparative GLP-1/GIP pathway studies, glucose tolerance protocols and adipose tissue signallingThe glucagon-receptor contribution: energy expenditure, lipid metabolism and hepatic glucose handling
Reported plasma half-life~1 week~5 days~6 days
CAS number910463-68-22023788-19-22381089-83-2
Molecular mass4113.6 g/mol4813.5 g/mol4731.4 g/mol
Vial sizes we sell5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 80mg, 100mg, 120mg5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 80mg, 100mg, 120mg
Price (10-vial pack)from $35.92 ($3.59 per vial)from $37.92 ($3.79 per vial)from $46.92 ($4.69 per vial)
Third-party test99.576% HPLC, Janoshik report #23882099.854% HPLC, Janoshik report #23881899.547% HPLC, Janoshik report #238816
Batch COA in our libraryNone listed yetTZ-2607RT-2605

Half-life, CAS and mass are published figures for the molecules. Prices and vial sizes are read live from our catalog.

How each is used in research

Semaglutide

Used as the reference single-receptor GLP-1 agonist, so a study that needs to isolate GLP-1 signalling usually starts here. It is the most-studied analog in metabolic research.

Sizes: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg · Semaglutide research hub

Tirzepatide

Adds GIP receptor activity to GLP-1, which makes it the natural comparator when the question is what GIP contributes on top of GLP-1 alone.

Sizes: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 80mg, 100mg, 120mg · Tirzepatide research hub

Retatrutide

Adds glucagon receptor activity to GLP-1 and GIP. That glucagon agonism is what separates it from the other two, and the newest of the three has a published literature that is still expanding rapidly.

Sizes: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 80mg, 100mg, 120mg · Retatrutide research hub

Questions

What is the difference between retatrutide, tirzepatide and semaglutide?

+

The number of receptors each one activates. Semaglutide is a single agonist of the GLP-1 receptor. Tirzepatide is a dual agonist of the GLP-1 and GIP receptors. Retatrutide is a triple agonist of the GLP-1, GIP and glucagon receptors. The glucagon agonism is what distinguishes retatrutide from the other two.

Which of the three has the longest plasma half-life?

+

The reported half-lives are ~1 week for semaglutide, ~6 days for retatrutide and ~5 days for tirzepatide, so semaglutide is longest. These are published pharmacokinetic figures for the molecules, not performance claims for a particular vial.

Does QSC publish independent test data for all three?

+

Yes. Janoshik Analytical HPLC purity reports are published for each: semaglutide 99.576% HPLC purity (Janoshik report #238820), tirzepatide 99.854% HPLC purity (Janoshik report #238818) and retatrutide 99.547% HPLC purity (Janoshik report #238816). Each report links to Janoshik's own verification page, and covers the sample it was run on.

Which vial sizes does QSC sell?

+

Every size is sold as a pack of ten vials. Semaglutide: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg. Tirzepatide: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 80mg, 100mg, 120mg. Retatrutide: 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg, 80mg, 100mg, 120mg.

QSC Peptidology products are sold strictly for laboratory and research use only. See also the Janoshik test reports and the other comparisons.